Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | RNA CART19 cells |
Synonyms | |
Therapy Description |
RNA CART19 cells are autologous T cells electroporated with RNA expressing CD19 chimeric antigen receptors consists of TCR zeta and 4-1BB costimulatory domains (PMID: 29925499). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RNA CART19 cells | RNA CART19 cells are autologous T cells electroporated with RNA expressing CD19 chimeric antigen receptors consists of TCR zeta and 4-1BB costimulatory domains (PMID: 29925499). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02624258 | Phase I | RNA CART19 cells | Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells in Patients With Refractory or Relapsed Hodgkin Lymphoma | Terminated | USA | 0 |